Abbott Laboratories (XSWX:ABT) Moat Score: 8/10 (As of Jun. 27, 2026)


XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF76.00
GF Value CHF104.56
View Full Analysis

What is Abbott Laboratories Moat Score?

Abbott Laboratories XSWX:ABT +0.66% 80 Moat Score is 8 as of Jun. 27, 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF104.56. Among 846 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 99.65% on this metric.

Abbott Laboratories has the Moat Score of 8, which implies that the company might have Wide Moat - Clear and robust wide moat.

Abbott Laboratories has Wide Moat: Abbott Laboratories has a robust wide moat due to its strong brand, extensive distribution network, and significant intellectual property. The company benefits from economies of scale, regulatory barriers, and consistent innovation, providing durable competitive advantages and strong pricing power in the healthcare sector.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Abbott Laboratories might have Wide Moat - Clear and robust wide moat.

Abbott Laboratories  (XSWX:ABT) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Abbott Laboratories Moat Score Related Terms

XSWX:ABT vs SYK, MDT, BSX: Moat Score Comparison

For the Medical Devices subindustry, Abbott Laboratories's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Moat Score distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Moat Score falls into.


XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 8 mean?
Abbott Laboratories (XSWX:ABT) has a Moat Score of 8 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Abbott Laboratories ranks #3 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 0.40000000000001%.
Is Abbott Laboratories' Moat Score too high?
Abbott Laboratories' current Moat Score is 8. Based on the distribution chart, Abbott Laboratories ranks #3 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Moat Score compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #3 out of 846 companies for Moat Score. This places Abbott Laboratories in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Abbott Laboratories's current Moat Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Moat Score of 8. The stock's GF Value™ is CHF104.56, compared to a current price of CHF76.00 — trading 27.3% below its estimated fair value. The current Moat Score is 8. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Moat Score is 8 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF76.00 is trading 27.3% below its estimated GF Value™ of CHF104.56.

Key valuation signals for XSWX:ABT:

  • Moat Score: 8
  • GF Value™: CHF104.56 vs. price of CHF76.00 (27.3% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF76.00
Price
CHF104.56
GF Value